ID: ALA2314635

Max Phase: Preclinical

Molecular Formula: C26H40Cl2N2O2S3

Molecular Weight: 508.82

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COCCc1sc[n+](CCCCc2ccc(CCCC[n+]3csc(CCOC)c3C)s2)c1C.[Cl-].[Cl-]

Standard InChI:  InChI=1S/C26H40N2O2S3.2ClH/c1-21-25(13-17-29-3)31-19-27(21)15-7-5-9-23-11-12-24(33-23)10-6-8-16-28-20-32-26(22(28)2)14-18-30-4;;/h11-12,19-20H,5-10,13-18H2,1-4H3;2*1H/q+2;;/p-2

Standard InChI Key:  YEHCCSABXMGEAA-UHFFFAOYSA-L

Associated Targets(Human)

Jurkat 10389 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium vinckei petteri 380 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasmodium falciparum 966862 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 508.82Molecular Weight (Monoisotopic): 508.2241AlogP: 5.49#Rotatable Bonds: 16
Polar Surface Area: 26.22Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: -1.00CX LogD: -1.00
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.19Np Likeness Score: -0.38

References

1. Caldarelli SA, El Fangour S, Wein S, Tran van Ba C, Périgaud C, Pellet A, Vial HJ, Peyrottes S..  (2013)  New bis-thiazolium analogues as potential antimalarial agents: design, synthesis, and biological evaluation.,  56  (2): [PMID:23289711] [10.1021/jm3014585]

Source